The Australian Dementia Network (ADNeT), Monash University, and Lilly Australia are proud to announce a new research collaboration aimed at deepening our understanding of the patient experience and societal impact of mild cognitive impairment and early Alzheimer’s disease. This landmark initiative represents the first collaboration of its kind in Australia between researchers, academia, and industry...
Read more
The Australian Dementia Network (ADNeT) welcomes the decision by the Therapeutic Goods Administration (TGA) to approve the use of donanemab in Australia. It is the first drug registered in Australia that has been proven to significantly slow the progression of Alzheimer’s disease. But it needs to be given at the first signs of the disease...
Read more
Welcome to the latest edition of the ADNeT newsletter. We are on the cusp of significant progress in new drugs and blood tests for preventing, diagnosing and treating dementia. It is a critical time to support the research driving these innovations. At this end of the financial year, your tax deductible donation will advance dementia...
Read more

Welcome to the official website of the Australian Dementia Network (ADNeT).

Whether you are a researcher, a health professional, or a member of the public, we hope our website provides you with relevant information on our works, a suite of valuable tools and other resources, and news on the latest advancements in dementia diagnosis, prevention, treatment, and care.

Resources

PET Reading Training

As part of the education component of ADNeT, Director Professor Christopher Rowe has prepared two training videos (Part 1 and Part 2) to help imaging specialists interpret PET scans.
Memory and Cognition Clinic Guidelines

National Service Guidelines for Specialised Dementia and Cognitive Decline Assessment Services in Australia.
All Resources

ADNeT resources for the general public, consumers, researchers and clinicians.

ADNeT Partners

Supported By